Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9.
Saved in:
| Title: | Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9. |
|---|---|
| Authors: | Ontiveros-Padilla L; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Hendy DA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Pena ES; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA., Williamson GL; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Murphy CT; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Lukesh NR; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Ashcraft KA; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States., Abraham MA; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States., Landon CD; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States., Staats HF; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States; Duke Human Vaccines Institute, School of Medicine, Duke University, Durham, NC, United States., Abraham SN; Departments of Pathology, Molecular Genetics and Microbiology and Immunology, Duke University School of Medicine, Durham, NC, United States., Carlock M; Florida Research and Innovation Center, Port Saint, Cleveland Clinic Florida, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States., Ross TM; Florida Research and Innovation Center, Port Saint, Cleveland Clinic Florida, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States., Petrovsky N; School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Flinders University, Adelaide, SA 5042, Australia; Vaxine Pty Ltd, 1 Flinders Lane, Bedford Park, Adelaide, SA 5042, Australia., Heise MT; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, USA., Bachelder EM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Ainslie KM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Aug 10; Vol. 384, pp. 113855. Date of Electronic Publication: 2025 May 18. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40393528 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ontiveros-Padilla+L%22">Ontiveros-Padilla L</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hendy+DA%22">Hendy DA</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pena+ES%22">Pena ES</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Williamson+GL%22">Williamson GL</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Murphy+CT%22">Murphy CT</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lukesh+NR%22">Lukesh NR</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ashcraft+KA%22">Ashcraft KA</searchLink>; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Abraham+MA%22">Abraham MA</searchLink>; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Landon+CD%22">Landon CD</searchLink>; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Staats+HF%22">Staats HF</searchLink>; Department of Pathology, School of Medicine, Duke University, Durham, NC, United States; Duke Human Vaccines Institute, School of Medicine, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Abraham+SN%22">Abraham SN</searchLink>; Departments of Pathology, Molecular Genetics and Microbiology and Immunology, Duke University School of Medicine, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Carlock+M%22">Carlock M</searchLink>; Florida Research and Innovation Center, Port Saint, Cleveland Clinic Florida, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.<br /><searchLink fieldCode="AU" term="%22Ross+TM%22">Ross TM</searchLink>; Florida Research and Innovation Center, Port Saint, Cleveland Clinic Florida, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.<br /><searchLink fieldCode="AU" term="%22Petrovsky+N%22">Petrovsky N</searchLink>; School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Flinders University, Adelaide, SA 5042, Australia; Vaxine Pty Ltd, 1 Flinders Lane, Bedford Park, Adelaide, SA 5042, Australia.<br /><searchLink fieldCode="AU" term="%22Heise+MT%22">Heise MT</searchLink>; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, USA.<br /><searchLink fieldCode="AU" term="%22Bachelder+EM%22">Bachelder EM</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ainslie+KM%22">Ainslie KM</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2025 Aug 10; Vol. 384, pp. 113855. <i>Date of Electronic Publication: </i>2025 May 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40393528 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2025.113855 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 113855 Titles: – TitleFull: Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ontiveros-Padilla L – PersonEntity: Name: NameFull: Hendy DA – PersonEntity: Name: NameFull: Pena ES – PersonEntity: Name: NameFull: Williamson GL – PersonEntity: Name: NameFull: Murphy CT – PersonEntity: Name: NameFull: Lukesh NR – PersonEntity: Name: NameFull: Ashcraft KA – PersonEntity: Name: NameFull: Abraham MA – PersonEntity: Name: NameFull: Landon CD – PersonEntity: Name: NameFull: Staats HF – PersonEntity: Name: NameFull: Abraham SN – PersonEntity: Name: NameFull: Carlock M – PersonEntity: Name: NameFull: Ross TM – PersonEntity: Name: NameFull: Petrovsky N – PersonEntity: Name: NameFull: Heise MT – PersonEntity: Name: NameFull: Bachelder EM – PersonEntity: Name: NameFull: Ainslie KM IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 08 Text: 2025 Aug 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 384 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |
